Metraipolis › archive › dc_1e787d13cb33
Fasting glucagon as an independent risk indicator for CAD in patient with type 2 diabetes — Europe PMC PMID:41458542
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41458542
- DOI
- 10.3389/fendo.2025.1749418
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T17:19:03.216Z
- SHA-256 of the archived text
e90ca6eea6326fea73454bfce8666eb16cbe9713acf86bfc265635beb627c6fb- Stable URL of this page
https://metraipolis.com/documento/dc_1e787d13cb33
How to cite
Fasting glucagon as an independent risk indicator for CAD in patient with type 2 diabetes — Europe PMC PMID:41458542 — Europe PMC (en), https://europepmc.org/article/MED/41458542 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1e787d13cb33 (Metraipolis archive dc_1e787d13cb33, sha256 e90ca6eea6326fea73454bfce8666eb16cbe9713acf86bfc265635beb627c6fb)
BibTeX
@misc{dc1e787d13cb33,
title = {Fasting glucagon as an independent risk indicator for CAD in patient with type 2 diabetes — Europe PMC PMID:41458542},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41458542},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1e787d13cb33; sha256 e90ca6eea6326fea73454bfce8666eb16cbe9713acf86bfc265635beb627c6fb},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41458542. Agents can read the archived copy with the MCP tool read_document.